Abstract
Background
After myocardial infarction (MI), inflammatory cells infiltrate the infarcted heart in response to secreted stimuli. Monocytes are recruited to the infarct via CCR2 chemokine receptors along a CCL2 concentration gradient. While infiltration of injured tissue with monocytes is an important component of the reparatory response, excessive or prolonged inflammation can adversely affect left ventricular remodeling and worsen clinical outcomes.
Materials and methods
Here, we developed poly(ethylene glycol) (PEG)-distearoylphos-phatidylethanolamine (PEG-DSPE) micelles loaded with a small molecule CCR2 antagonist to inhibit monocyte recruitment to the infarcted myocardium. To specifically target CCR2-expressing cells, PEG-DSPE micelles were further surface decorated with an anti-CCR2 antibody.
Results
Targeted PEG-DSPE micelles showed eight-fold greater binding to CCR2-expressing RAW 264.7 monocytes than plain, non-targeted PEG-DSPE micelles. In a mouse model of MI, CCR2-targeting PEG-DSPE micelles loaded with a CCR2 small molecule antagonist significantly decreased the number of Ly6Chigh inflammatory cells to 3% of total compared with PBS-treated controls. Furthermore, CCR2-targeting PEG-DSPE micelles significantly reduced the infarct size based on epicardial and endocardial infarct arc lengths.
Conclusion
Both non-targeted and CCR2-targeting PEG-DSPE micelles showed a trend toward improving cardiac function. As such, PEG-DSPE micelles represent a promising cardiac therapeutic platform.
Acknowledgments
We would like to thank Dr Joseph Spernyak (Roswell Park Cancer Institute) for technical assistance in the use of the IVIS Spectrum in vivo imager and funding by the NIH (S10 OD 016450). We acknowledge support by the NIH through awards HL-126082 (JN&JMC), EB-021454 (JN), EB-023262 (JN), HL-61610 (JMC), the National Center for Advancing Translational Sciences UL1-TR-001412 and the Department of Veterans Affairs 1IO1BX002659 (JMC).
Disclosure
The authors report no conflicts of interest in this work.